STAT3 and chronic myelogenous leukemia, BCR-ABL1 positive: Hyperactivation of JAK2/STAT3 signaling transduces oncogenic signals to promote CML cells growth, leukemia stem cells survival and therapeutic resistance, thus disease evolution (Stella et al., 2013).